Sonic Healthcare – Buy

SHL:ASX is under Algo Engine buy conditions and is a current holding in our ASX model portfolio.

FY22 revenue is likely to be around $7.6bn on EBITDA of $1.7bn. EPS growth will moderate to 5 – 10%, which will continue to support a forward yield of 3.5%.

You’re not a member!  Trial today

The short-term momentum indicators are now pointing higher, as buying increases above the $30 support level.

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.